TickerFactsScreenerDevelopers

BIOMARIN PHARMACEUTICAL INC (BMRN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2008: -$9.18M2009: $87.73M2010: $18.75M2011: $18.41M2012: $17.61M2013: -$59.63M2016: -$227.84M2017: -$8.76M2018: $20.21M2019: $48.26M2020: $85.36M2021: $304.54M2022: $175.90M2023: $159.26M2024: $572.84M2025: $827.99M$827.99M
2008Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$827.99M+44.5%
2024$572.84M+259.7%
2023$159.26M-9.5%
2022$175.90M-42.2%
2021$304.54M+256.7%
2020$85.36M+76.9%
2019$48.26M+138.8%
2018$20.21M+330.8%
2017-$8.76M+96.2%
2016-$227.84M—
2013-$59.63M-438.7%
2012$17.61M-4.4%
2011$18.41M-1.8%
2010$18.75M-78.6%
2009$87.73M+1056.2%
2008-$9.18M—